Organic Active Ingredients TRIZ Cases

A non-newtonian opioid composition uses clay and controlled release agents to create a physicochemical barrier against extraction.

Segmented CAR-T dosing overcomes tumor microenvironment barriers to improve anti-tumor efficacy.

Super-enhancers increase target gene expression levels by concentrating transcriptional coactivators to maintain cell identity.

Optimized pore structures enable a single sorbent to capture diverse toxins, replacing the need for multiple specific antidotes.

Aminomethyl azaadamantane derivatives selectively modulate alpha7 and alpha4beta2 nicotinic acetylcholine receptors.

A real-time release testing method establishes a design space using material attributes to ensure consistent product quality.

Antisense oligonucleotides target PNPLA3 mRNA to lower protein levels, addressing inadequate treatment efficacy for non-alcoholic fatty liver disease.

Small molecule inhibitors target abnormal FGFR3 signaling to treat achondroplasia without invasive orthopedic surgery.

Sealed trays hold vials, diluents, and syringes to reconstitute unstable mitomycin-C into absorbent pads, reducing toxicity risks during ophthalmic procedures.

A water-free beeswax and jojoba oil composition applies to the eyelid to form a protective film on the ocular surface.

Pulsatile solabegron release cycles high and low plasma concentrations, allowing beta-3 adrenoceptors to recover from desensitization.

Oral composition combining spirulina with aqueous pollen cytoplasm extract to activate the immune system through enhanced cytokine production.

Dynamic nirogacestat dosing reduces severe side effects like diarrhea while maintaining therapeutic efficacy for desmoid tumors.

Optimized cationic lipids resolve low introduction efficiency across diverse cell types by forming stable electrostatic complexes.

Phage display generates sLea-specific antibodies to differentiate malignancy from pancreatitis.

A cyclic guanidine compound in yogurt promotes glucocerebrosidase activity through enzyme stabilization.

Phospholipids solubilize American cranberry extract to overcome poor bioavailability and ensure effective urinary concentrations of active metabolites.

Localizing endothelin B receptor activation increases tumor perfusion, resolving the trade-off between systemic toxicity and treatment efficacy.

Novel macrocyclic pyrimidine compounds address limited treatment options by simultaneously inhibiting EF2K and Vps34 kinases for cancer therapy.

Targeted PDE10A inhibition reduces side effects from broad receptor blocking while maintaining therapeutic efficacy for schizophrenia.

Substituted imidazopyridinyl-aminopyridine compounds selectively inhibit AKT proteins to induce cell death in cancer cells.

Nucleoside phosphoramidate prodrugs bypass initial activation steps to inhibit HCV NS5B polymerase, overcoming resistance in current therapies.

Segmented cannabis particles under 500 nm improve dissolution consistency, reducing required doses to mitigate side effects.

Segmented reaction steps and parameter optimization overcome scale-up difficulties to produce 1,8-naphthyridines at kilogram quantities.

Formula I compounds induce autophagy via specific molecular substituents to resolve systemic treatment efficacy.

Compounds targeting the conserved gp120 Phe43 cavity sensitize variable HIV-1 strains to CD4-induced antibodies, overcoming surface variability challenges.

Cis-disposed azabicyclo hexane derivatives improve dopamine D3 receptor affinity while reducing off-target effects on D2 receptors.

Isotopically modified polyunsaturated fatty acids stabilize molecular bonds against oxidative damage through deuterium substitution.

Cyclopentane compounds bind STING to induce type 1 interferons, addressing limited clinical activators.

Hydroxybenzoic acid esters reduce viral loads while avoiding skin irritation caused by podophyllotoxin treatments.

N-benzyl tryptanthrin derivatives block tryptophan dioxygenase activity, addressing limited research coverage for severe diseases like liver cancer.

Injecting Botulinum Toxin Type A into the flexor digitorum profundus muscle relaxes deep digital flexor tendon tension.

Covalent modification of conserved cysteine residues in JNKs overcomes poor selectivity and efficacy limits of reversible inhibitors.

Small molecule compounds bind to sortilin to stabilize the protein and increase glucose uptake in adipocytes.

Targeting KRAS G12C mutants bypasses EGFR therapy resistance, expanding treatment options for patients with advanced pancreatic and colorectal cancers.

Specific 7-azaindole derivatives resolve the selectivity trade-off by inhibiting AXL kinase without affecting other kinases, preventing viral replication.

Topical tocopherol ester composition neutralizes allergens and protects nasal mucosa, reducing side effects from conventional antihistamines.

Crystal form A of tetramethylpyrazine nitrone stabilizes the compound through controlled solvent crystallization, eliminating polymorphic transformations.

17beta-androstane derivatives reduce restenosis and liver fibrosis by inhibiting cellular proliferation, addressing ineffective current pharmaceutical agents.

Microcrystalline plate structures in co-processed carbohydrates resolve the trade-off between tablet strength and disintegration time.

Filtration removes blood cell contaminants to boost therapeutic effectiveness.

Adding Nintedanib to BRAF and MEK inhibitors prevents abnormal fibrotic stromal reactions, delaying tumor relapse and overcoming therapy resistance.

Small molecule compounds modulate chemokine activity and inhibit kinase activity to treat diseases associated with uncontrolled cell migration.

Polymeric buccal films with phenylpropanoids overcome mucosal barrier resistance to boost epinephrine bioavailability.

Sodium salt polymorphs of tyrosine kinase inhibitors enhance oral bioavailability through optimized solid-state structures.

Administering oral proinsulin alongside a JAK inhibitor reduces memory T cell generation to delay type 1 diabetes onset without continuous dosing.

Formula I quinazolines normalize neurotransmitter levels by inhibiting DAT, SERT, and NET simultaneously to treat depression and pain.

Giant multi-lamellar vesicles comprising lecithin resist stomach acid and digestive enzymes to protect encapsulated cargo.

A steroid-cationic lipid compound forms stable lipid nanoparticles that deliver mRNA to target cells with high transfection efficiency.

Topical perfluorodecalin resolves whitening reactions to reduce treatment time and prevent burns.

Novel indole and benzoxazine derivatives act as positive allosteric modulators of the metabotropic glutamate receptor subtype 2.

Acacia mediates interactions between levothyroxine and carbohydrate excipients to prevent rapid drug degradation and extend shelf life.

Isolating polymorph C overcomes blood-brain barrier blocking to increase drug concentration in brain tissue.

Modifying substituent positions on the cannabinoid core enhances anticonvulsant activity while reducing psychoactive side effects in mouse models.

Synchronizing zanthoxylum extract administration with circadian rhythms resolves the contradiction between enhanced synthesis and suboptimal moisture retention.

PEGylated morphinan derivatives alleviate neuropathic pain while minimizing central side effects like addiction.

Soluble ActRIIB polypeptides bind inhibitory ligands to raise circulating adiponectin concentrations, addressing hypoadiponectinemia risks.

Novel glucocorticoids featuring a 17α furoate group enhance receptor affinity to deliver potent anti-inflammatory activity at lower doses.

Imidazopyrimidine compounds modulate skeletal muscle proteins to treat metabolic and neuromuscular disorders.

Rapid mixing in a micro chamber forms stable lipid-nucleic acid particles, reducing nuclease degradation and toxicity during in vivo delivery.

Empty lipid nanoparticle compositions enable post-hoc nucleic acid loading via high zeta potential, resolving instability and permeability bottlenecks.

Maltodextrin and sorbitol granulation prevents metal complex formation, maintaining product purity and storage stability.

Enzymatic synthesis of human milk oligosaccharide mixtures using alpha1-3/4 transfucosidase to produce defined molar ratios.

Solid PEG compositions form a hydrating layer on vaginal mucosa to improve tissue trophism without systemic side effects.

Liquid oil esters solubilize corticosteroids at reduced concentrations to maintain dermatological potency while minimizing systemic side effects.

Engineered interchain cysteine residues enable precise drug attachment, resolving variability in drug-to-antibody ratios and reducing systemic toxicity.

Hydroxyl-free adhesive base and metal salt desalting prevent ropinirole analogue formation, ensuring stable transdermal absorbability.

A single-stranded nucleic acid molecule uses a pyrrolidine or piperidine linker to join complementary regions for self-annealing.

Optimizing crystallization parameters yields a stable anhydrous form that resolves the contradiction between therapeutic stability and manufacturing purity.

4-substituted pyrrolo[2,3-b]pyridine compounds covalently modify cysteine residues in EGFR and Her2 kinases to block receptor activity.

Optimized mRNA encoding Cas9 reduces immune responses and vector integration risks through lipid nanoparticle formulation.

Segmented chemical synthesis of guide molecules avoids n-1 and n+1 contamination while maintaining full-length sequence fidelity.

Optimized 1-25 microM oligonucleotide concentrations reduce toxicity while maintaining effective tumor growth inhibition.

Novel tetrahydrobenzothiazole derivatives act as selective dopamine D3 receptor ligands.

Conjugating small molecule agonists with polypeptides enhances IFN-γ and IL-12 induction, addressing weak antitumor immune responses.

Chemically modified miR-143 derivatives enhance cellular stability and tumor growth inhibition through targeted sequence optimization.

Formula I compounds target the IRAK4 pathway to reduce pro-inflammatory cytokine and type I interferon production in rheumatoid arthritis and cancer.

Applying a viral inhibitor prevents baculovirus spreading during low MOI infection, enabling reliable identification of individual genes in pooled libraries.

Rhamnose polysaccharides inhibit Malassezia furfur growth while minimizing toxicity risks associated with conventional antifungal agents.

An anti-CD38 antibody delivers attenuated interferon alpha-2b to tumor cells.

Selective alpha-2A and 2C agonists alleviate chronic pain while avoiding the sedative side effects common with non-selective treatments.

Pharmaceutical composition uses enzyme activation to degrade opioids, preventing abuse while maintaining therapeutic delivery.

Tricyclic heterocyclic compounds inhibit KRAS GTP activity, resolving the trade-off between therapeutic efficacy and oral deliverability.

Antibodies targeting SIGLEC-15 inhibit osteoclast differentiation, reducing bone resorption and side effects in osteoporosis treatment.

Bioactive composite scaffolds mimic natural bone extracellular matrices to enhance osteogenic differentiation and resolve fibrotic tissue formation.

Non-peptidic compounds mimic phosphotyrosine residues to block STAT3 dimerization, resolving stability and affinity trade-offs in cancer therapy.

dsRNA agents target HDLBP mRNA via RISC cleavage, reducing plasma cholesterol and atherosclerotic plaque formation without statin side effects.

Crystalline succinate salts of Syk inhibitors improve pharmacokinetic profiles by reducing hepatocyte clearance while maintaining kinase inhibition efficacy.

Pentameric, trimeric, and tetrameric procyanidins enhance oxygen and nutrient delivery to resolve insufficient circulation and prolonged healing times.

Topical rifamycin formulations deliver therapeutic agents to the retina without invasive procedures.

Novel spiro-piperidine structures target beta-secretase activity, reducing A-beta deposits and addressing progression of neurodegenerative diseases.

Pegylated perfluorocarbon nanoparticles conjugated with collagen IV targeting peptides deliver drugs to glomerular basement membranes.